- Home
- TBPH vs DJTWW Comparison
TBPH vs DJTWW Comparison
Compare TBPH & DJTWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBPH | DJTWW |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 908.9M | 752.7M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TBPH | DJTWW |
|---|---|---|
| Price | $17.03 | $4.86 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.40 | N/A |
| AVG Volume (30 Days) | ★ 345.7K | 22.0K |
| Earning Date | 05-04-2026 | 04-02-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 279.13 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,386,000.00 | $3,682,600.00 |
| Revenue This Year | $8.46 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1.76 |
| 52 Week Low | $13.08 | $2.56 |
| 52 Week High | $21.03 | $11.45 |
Technical Indicators
Market Signals| Indicator | TBPH | DJTWW |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 60.90 |
| Support Level | $16.80 | $4.73 |
| Resistance Level | $17.11 | $5.39 |
| Average True Range (ATR) | 0.06 | 0.32 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 15.69 | 49.09 |
Price Performance
Historical ComparisonAbout TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
About DJTWW Trump Media & Technology Group Corp.
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.